https://www.selleckchem.com/pr....oducts/pexidartinib-
To prospectively evaluate the safety and efficacy of embolization using ethylene vinyl alcohol copolymer (Onyx ) and Aetoxysclerol for treatment of pelvic venous disorders (PeVD). This prospective study was approved by the institutional ethics review board. Ten clinical parameters were retained for evaluation of PeVD (pelvic pain, dyspareunia, post-coital pain, menstruation pain, lower limbs pain, difficulty walking, aesthetic discomfort, impact on daily working life, psychological impact and impact on daily life), measured
Mi piace
Commento
Condividi
